Literature DB >> 25172178

Animal models in primary biliary cirrhosis and primary sclerosing cholangitis.

Marion J Pollheimer1, Peter Fickert.   

Abstract

Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are immune-mediated cholangiopathies with enigmatic etiology and pathogenesis. They have distinct clinical, laboratory, immunological, and histomorphological characteristics. Well-characterized animal models for PBC and PSC are utterly needed to develop novel pathogenetic concepts and to study innovative treatment strategies. The aim of the current paper is to outline the characteristics of ideal PBC and PSC animal models and to contrast this with a real-life up-to-date overview of currently available mouse models. Although some of this models show several individual characteristics of PBC and PSC, it is obvious that all of them have substantial and important limitations. Nevertheless, some may be beneficial to study certain pathophysiological aspects. Potential cholangiopathy animal models should be systematically investigated in regard to elevated serum alkaline phosphatase, bilirubin, and bile acid levels; immunological abnormalities; and longitudinal studies in regard to their liver phenotype. We herein propose a common systematic workup for potential models based on the fact that there are some intriguing disease combinations in specific genetically modified mice and recommend a stepwise process in regard to model characterization with methodical harvesting and screening of numerous organs for potential concomitant diseases. Due to the complex nature of both cholangiopathies, it seems to be very likely that no single perfect PBC or PSC model will ever be generated. The models outlined herein will certainly help to clarify specific pathogenetic aspects and even more important may turn out to be suitable to test potential drugs for treatment.

Entities:  

Mesh:

Year:  2015        PMID: 25172178     DOI: 10.1007/s12016-014-8442-y

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  104 in total

1.  Induction of heme oxygenase 1 prevents progression of liver fibrosis in Mdr2 knockout mice.

Authors:  Roja Barikbin; Daniel Neureiter; Jan Wirth; Annette Erhardt; Dorothee Schwinge; Johannes Kluwe; Christoph Schramm; Gisa Tiegs; Gabriele Sass
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

2.  Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice.

Authors:  J R Mead; M J Arrowood; R W Sidwell; M C Healey
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

3.  Assessment of biliary bicarbonate secretion in humans by positron emission tomography.

Authors:  J Prieto; N García; J M Martí-Climent; I Peñuelas; J A Richter; J F Medina
Journal:  Gastroenterology       Date:  1999-07       Impact factor: 22.682

4.  Spontaneous occurrence of chronic non-suppurative destructive cholangitis and antimitochondrial autoantibodies in MRL/lpr mice: possible animal model for primary biliary cirrhosis.

Authors:  K Tsuneyama; M Nose; M Nisihara; K Katayanagi; K Harada; Y Nakanuma
Journal:  Pathol Int       Date:  2001-06       Impact factor: 2.534

5.  Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice.

Authors:  Sabine Oertelt; Zhe-Xiong Lian; Chun-Mei Cheng; Ya-Hui Chuang; Kerstien A Padgett; Xiao-Song He; William M Ridgway; Aftab A Ansari; Ross L Coppel; Ming O Li; Richard A Flavell; Mitchell Kronenberg; Ian R Mackay; M Eric Gershwin
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

6.  Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.

Authors:  Peter Fickert; Gernot Zollner; Andrea Fuchsbichler; Conny Stumptner; Andreas H Weiglein; Frank Lammert; Hanns-Ulrich Marschall; Oleksiy Tsybrovskyy; Kurt Zatloukal; Helmut Denk; Michael Trauner
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

7.  Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis.

Authors:  January T Salas; Jesús M Banales; Sarai Sarvide; Sergio Recalde; Alex Ferrer; Iker Uriarte; Ronald P J Oude Elferink; Jesús Prieto; Juan F Medina
Journal:  Gastroenterology       Date:  2008-02-14       Impact factor: 22.682

8.  Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth.

Authors:  S N Lichtman; J Keku; J H Schwab; R B Sartor
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

9.  Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-/-) mice.

Authors:  Willy Hsu; Weici Zhang; Koichi Tsuneyama; Yuki Moritoki; William M Ridgway; Aftab A Ansari; Ross L Coppel; Zhe-Xiong Lian; Ian Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

10.  Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model.

Authors:  Peter R Durie; Geraldine Kent; M James Phillips; Cameron A Ackerley
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

View more
  17 in total

Review 1.  Current strategies to generate mature human induced pluripotent stem cells derived cholangiocytes and future applications.

Authors:  Eduardo Cervantes-Alvarez; Yang Wang; Alexandra Collin de l'Hortet; Jorge Guzman-Lepe; Jiye Zhu; Kazuki Takeishi
Journal:  Organogenesis       Date:  2017-01-05       Impact factor: 2.500

2.  Fibrin deposition following bile duct injury limits fibrosis through an αMβ2-dependent mechanism.

Authors:  Nikita Joshi; Anna K Kopec; Jessica L Ray; Holly Cline-Fedewa; Atta Nawabi; Timothy Schmitt; Rance Nault; Timothy R Zacharewski; Cheryl E Rockwell; Matthew J Flick; James P Luyendyk
Journal:  Blood       Date:  2016-02-26       Impact factor: 22.113

3.  Unmet challenges in immune-mediated hepatobiliary diseases.

Authors:  Ulrich Beuers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

4.  Effects of human amnion-derived mesenchymal stem cells and conditioned medium in rats with sclerosing cholangitis.

Authors:  Ryo Sugiura; Shunsuke Ohnishi; Masatsugu Ohara; Marin Ishikawa; Shuichi Miyamoto; Reizo Onishi; Koji Yamamoto; Kazumichi Kawakubo; Masaki Kuwatani; Naoya Sakamoto
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

5.  Mammalian Target of Rapamycin Complex 2 Signaling Is Required for Liver Regeneration in a Cholestatic Liver Injury Murine Model.

Authors:  Yi Zhou; Meng Xu; Pin Liu; Binyong Liang; Manning Qian; Haichuan Wang; Xinhua Song; Pranavanand Nyshadham; Li Che; Diego F Calvisi; Feng Li; Shumei Lin; Xin Chen
Journal:  Am J Pathol       Date:  2020-04-07       Impact factor: 4.307

Review 6.  Animal models of biliary injury and altered bile acid metabolism.

Authors:  Valeria Mariotti; Mario Strazzabosco; Luca Fabris; Diego F Calvisi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-11       Impact factor: 5.187

7.  Trichloroethylene Exposure Reduces Liver Injury in a Mouse Model of Primary Biliary Cholangitis.

Authors:  Jessica L Ray; Anna K Kopec; Nikita Joshi; Holly Cline-Fedewa; Lawrence H Lash; Kurt J Williams; Patrick S Leung; M Eric Gershwin; James P Luyendyk
Journal:  Toxicol Sci       Date:  2017-04-01       Impact factor: 4.849

Review 8.  Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets.

Authors:  Keisaku Sato; Shannon Glaser; Lindsey Kennedy; Suthat Liangpunsakul; Fanyin Meng; Heather Francis; Gianfranco Alpini
Journal:  Expert Opin Ther Targets       Date:  2019-04-22       Impact factor: 6.902

Review 9.  Proposed therapies in primary biliary cholangitis.

Authors:  Annarosa Floreani; Ying Sun; Zheng Sheng Zou; Baosen Li; Nora Cazzagon; Christopher L Bowlus; M Eric Gershwin
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2016-01-06       Impact factor: 3.869

10.  Proteomic analysis reveals distinctive protein profiles involved in CD8+ T cell-mediated murine autoimmune cholangitis.

Authors:  Weici Zhang; Ren Zhang; Jun Zhang; Ying Sun; Patrick Sc Leung; Guo-Xiang Yang; Zongwen Shuai; William M Ridgway; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.